financetom
CRH
financetom
/
Materials
/
CRH
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
CRH plcCRH
93.64USD
+0.58 (0.62%)
Dec 20, 2024, 4:00 PM EST - Market closed
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
63.52B
Revenue (ttm)
35.39B
Net Income (ttm)
3.45B
Shares Out
678.32M
EPS (ttm)
4.98
PE Ratio
18.80
Forward PE
16.06
Dividend
$2.38 (2.54%)
Ex-Dividend Date
Aug 23, 2024
Volume
3,386,462
Open
92.85
Previous Close
93.06
Day's Range
92.80 - 94.46
52-Week Range
65.74 - 104.23
Beta
1.37
Analysts
Strong Buy
Price Target
105.55 (+12.72%)
Earnings Date
Feb 16, 2025
Description >

CRH plc, through its subsidiaries, manufactures and distributes building materials in Ireland and internationally.

It operates through three segments: Americas Materials, Europe Materials, and Building Products. The company manufactures and supplies cement, lime, aggregates, precast, ready mixed concrete, and asphalt products; concrete masonry and hardscape products comprising pavers, kerbs, retaining walls, and related patio products; It also offers precast concrete and polymer-based products, such as underground vaults, drainage pipes and structures, utility enclosures, and modular precast structures to the water, energy, communication, transportation, and building structures markets; and construction accessories, such as engineered anchoring, fixing, and connection solutions, as well as lifting systems, formwork accessories, and other accessories used in construction applications.

In addition, the company offers network access products, which include composite access chambers, covers, passive safety systems, retention sockets, sealants, and meter boxes; and paving and construction services.

Further, it provides building and civil engineering contracting, contract surfacing, operates logistics and owned railway infrastructure; sells and distributes cement; and supplies access chambers and ducting products.

CRH plc was founded in 1936 and is headquartered in Dublin, Ireland.

Latest News >
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
May 7, 2024
SAO PAULO, May 7 (Reuters) - Competing Brazilian meatpackers have joined forces to circumvent problems caused by heavy flooding in Rio Grande do Sul state, where torrential rains severely disrupted operations, a local meat lobby said on Tuesday. Jose Ribas, who presides over Sindicarne in the neighboring state of Santa Catarina, said local meatpackers were working in partnership to overcome...
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
May 7, 2024
12:28 PM EDT, 05/07/2024 (MT Newswires) -- Exxon Mobil ( XOM ) plans to set up a single North American research and technology hub at its Houston headquarters and close campuses in Clinton, New Jersey, and Sarnia in Ontario, Bloomberg reported Tuesday, citing a company spokeswoman. The majority of 700 workers affected by the closures are being offered roles in...
Campari has taste for more M&A after Courvoisier deal, new CEO says
Campari has taste for more M&A after Courvoisier deal, new CEO says
May 7, 2024
MILAN, May 7 (Reuters) - Campari will seek further M&A opportunties after completing the buyout of French cognac house Courvoisier, the new head of the Italian drinks group said on Tuesday. The group completed the 1.22-billion euro ($1.3 billion)acquisition of Courvoisier last week, earlier than expected by analysts. It was the largest ever deal for Campari, whose brands include the...
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
May 7, 2024
12:24 PM EDT, 05/07/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) and Agenus ( AGEN ) said Tuesday they have signed a royalty financing agreement to support the clinical development of Agenus' ( AGEN ) botensilimab and balstilimab, including a confirmatory phase 3 trial in metastatic, relapsed or refractory colorectal cancer. Under the terms of the agreement, Ligand will...
Copyright 2023-2024 - www.financetom.com All Rights Reserved